APA (7th ed.) Citation

XX, Y., GL, Y., YJ, Y., YH, H., L, Y., & YF, Z. (2025). Brutons tyrosine kinase inhibitor Zanubrutinib modulates Fc gamma receptors to inhibit platelet destruction for alleviation of refractory immune thrombocytopenia. Hematology (Amsterdam, Netherlands), 30(1), 2545078. https://doi.org/10.1080/16078454.2025.2545078

Chicago Style (17th ed.) Citation

XX, Yang, Yao GL, Yang YJ, Han YH, Yang L, and Zhang YF. "Brutons Tyrosine Kinase Inhibitor Zanubrutinib Modulates Fc Gamma Receptors to Inhibit Platelet Destruction for Alleviation of Refractory Immune Thrombocytopenia." Hematology (Amsterdam, Netherlands) 30, no. 1 (2025): 2545078. https://doi.org/10.1080/16078454.2025.2545078.

MLA (9th ed.) Citation

XX, Yang, et al. "Brutons Tyrosine Kinase Inhibitor Zanubrutinib Modulates Fc Gamma Receptors to Inhibit Platelet Destruction for Alleviation of Refractory Immune Thrombocytopenia." Hematology (Amsterdam, Netherlands), vol. 30, no. 1, 2025, p. 2545078, https://doi.org/10.1080/16078454.2025.2545078.